Free Trial
→ Out of 18,347 Cryptocurrencies... This is the ONLY One (From Crypto 101 Media) (Ad)tc pixel Free IOVA Stock Alerts

Iovance Biotherapeutics (IOVA) SEC Filings & 10K Form

Iovance Biotherapeutics logo
$2.02 -0.10 (-4.72%)
Closing price 04:00 PM Eastern
Extended Trading
$2.04 +0.02 (+0.74%)
As of 06:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Iovance Biotherapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
09/04/2025
5:35 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
5:30 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
5:30 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
5:30 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2025
3:06 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2025
4:15 PM		Iovance Biotherapeutics (Filer)
Form 424B5
08/22/2025
4:18 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2025
12:46 PM		Iovance Biotherapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
07/17/2025
7:12 PM		BlackRock, Inc. (Filed by)
Iovance Biotherapeutics (Subject)
Form SCHEDULE 13G/A
07/15/2025
6:36 AM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
4:15 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2025
4:15 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2025
3:46 PM		Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:47 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:49 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:50 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:51 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
4:15 PM		Iovance Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2025
4:00 PM		Iovance Biotherapeutics (Filer)
Form ARS
04/28/2025
4:00 PM		Iovance Biotherapeutics (Filer)
Form DEF 14A
04/28/2025
4:05 PM		Iovance Biotherapeutics (Filer)
Form DEFA14A
03/18/2025
7:30 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:05 PM		Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:05 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:06 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:06 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:06 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:32 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:32 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:33 PM		Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:30 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:31 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:15 PM		Iovance Biotherapeutics (Issuer)
Kirby Daniel Gordon (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/12/2025
4:17 PM		Iovance Biotherapeutics (Issuer)
Kirby Daniel Gordon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:22 AM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2025
4:59 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
5:00 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
5:01 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
4:15 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
4:16 PM		Iovance Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/02/2024
4:25 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/21/2024
4:15 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:50 PM		Iovance Biotherapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
11/12/2024
6:11 PM		Iovance Biotherapeutics (Subject)
Maynard Ryan D (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
8:03 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
4:15 PM		Iovance Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2024
7:38 AM		Iovance Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/16/2024
5:30 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
5:32 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
5:33 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:IOVA) was last updated on 9/25/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsoredtc pixel
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...
SmartAsset | Sponsoredtc pixel
A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...
Investors Alley | Sponsoredtc pixel
Strange crypto pattern discovered by 40-person research team
Something unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...
Crypto Swap Profits | Sponsoredtc pixel
Forget NVDA. Put $1,000 into this stock now
A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...
Chaikin Analytics | Sponsoredtc pixel
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsoredtc pixel